Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

Development of a Health Promotion Nursing Intervention for Post-traumatic Stress Women Based on Swanson's Theory of Caring

Not Applicable

Completed

Conditions: Women Who Have Experienced Trauma

Interventions: Other: Health Promotion Nursing Intervention

First Posted Date: 2021-11-12

Last Posted Date: 2021-11-12

Lead Sponsor: Yonsei University

Target Recruit Count: 14

Registration Number: NCT05118438

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Analysis of Clinical featuRes and Echocardiographic Characteristics for Diagnosis of Infiltrative cardiomyopaThy (ACREDIT): Retrospective Multi-center Observational Study

Conditions: Infiltrative Cardiomyopathy

First Posted Date: 2021-11-04

Last Posted Date: 2021-11-04

Lead Sponsor: Yonsei University

Target Recruit Count: 500

Registration Number: NCT05108168

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Division of Cardiology, Seoul, Korea, Republic of

Economic and Clinical Benefit of Remote Monitoring Among Defibrillator Patients by Indication Subgroups (BENEFIT-RM)

Not Applicable

Recruiting

Conditions: Patients With Defibrillator

Interventions: Device: on remote monitoring

First Posted Date: 2021-11-03

Last Posted Date: 2024-08-23

Lead Sponsor: Yonsei University

Target Recruit Count: 1140

Registration Number: NCT05106062

Locations: 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases

Phase 2

Recruiting

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: IV FOLFIRI+ target agent (bevacizumab or cetuximab) every 2 weeks
Drug: intra-arterial oxaliplatin + Systemic FOLFIRI + target agent (bevacizumab or cetuximab) every 2 weeks

First Posted Date: 2021-11-02

Last Posted Date: 2021-11-02

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT05103020

Locations: 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection

Not Applicable

Recruiting

Conditions: Adenocarcinoma of the Colon

Interventions: Procedure: Extracorporeal anastomosis
Procedure: Intracorporeal anastomosis

First Posted Date: 2021-10-14

Last Posted Date: 2021-10-14

Lead Sponsor: Yonsei University

Target Recruit Count: 241

Registration Number: NCT05077358

Locations: 🇰🇷
Yonsei University College of Medicine, Seoul, Korea, Republic of

Biobank of Lung Ultrasonography in Children Undergoing General Anesthesia

Recruiting

Conditions: Children Aged 6 Months to 10 Years Old Under General Anesthesia

First Posted Date: 2021-10-06

Last Posted Date: 2023-05-10

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT05069337

Locations: 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma

Phase 2

Conditions: Resectable Pancreatic Adenocarcinoma

Interventions: Drug: neoadjuvant modified FOLFIRINOX

First Posted Date: 2021-10-04

Last Posted Date: 2021-10-04

Lead Sponsor: Yonsei University

Target Recruit Count: 27

Registration Number: NCT05066802

Locations: 🇰🇷
Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine, Korea, Seoul, Korea, Republic of

da Vinci SP Robotic Gastrectomy

Not Applicable

Completed

Conditions: Gastric Cancer

Interventions: Procedure: da vinc SP gastrectomy

First Posted Date: 2021-09-21

Last Posted Date: 2023-06-27

Lead Sponsor: Yonsei University

Target Recruit Count: 19

Registration Number: NCT05051670

Locations: 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer

Phase 2

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: atezolizumab / tiragolumab

First Posted Date: 2021-09-05

Last Posted Date: 2021-09-05

Lead Sponsor: Yonsei University

Target Recruit Count: 45

Registration Number: NCT05034055

Locations: 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Impact of High-flow Nasal Oxygen During Awake Fiberoptic Bronchoscope Guided Intubation: A Retrospective Study

Conditions: Awake Fiberoptic Bronchoscope Guided Intubation

First Posted Date: 2021-08-26

Last Posted Date: 2021-08-26

Lead Sponsor: Yonsei University

Target Recruit Count: 200

Registration Number: NCT05022056

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy